Literature DB >> 19667222

Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability.

Daniel S Reich1, Seth A Smith, Eliza M Gordon-Lipkin, Arzu Ozturk, Brian S Caffo, Laura J Balcer, Peter A Calabresi.   

Abstract

OBJECTIVE: To determine whether damage to the optic radiation (OR) in multiple sclerosis (MS) is associated with optic nerve injury and visual dysfunction.
DESIGN: Case-control study.
SETTING: Referral center. PARTICIPANTS: Ninety referred patients with MS and 29 healthy volunteers. MAIN OUTCOME MEASURES: Magnetic resonance imaging indices along the OR were reconstructed with diffusion tensor tractography. Retinal nerve fiber layer thickness and visual acuity at high and low contrast were measured in a subset of the MS group (n = 36).
RESULTS: All tested magnetic resonance imaging indices (fractional anisotropy [FA]; mean, parallel, and perpendicular [lambda( perpendicular)] diffusivity; T2 relaxation time; and magnetization transfer ratio) were significantly abnormal in patients with MS. Mean retinal nerve fiber layer thickness was significantly correlated with FA (r = 0.55; P < .001) and lambda( perpendicular) (r = -0.37; P = .001). The retinal nerve fiber layer thickness in the nasal retinal quadrant was also specifically correlated with FA and lambda( perpendicular) in the synaptically connected contralateral OR. In individuals with less severely damaged optic nerves (mean retinal nerve fiber layer thickness >80 mum), letter acuity scores at 2.5% contrast were correlated with OR-specific FA (r = 0.55; P = .004), lambda( perpendicular) (r = -0.40; P = .04), and magnetization transfer ratio (r = 0.54; P = .01), as well as the fraction of OR volume made up of lesions (r = -0.69; P < .001).
CONCLUSIONS: Fractional anisotropy and lambda( perpendicular) are potentially useful quantitative magnetic resonance imaging biomarkers of OR-specific damage in MS. Such damage is associated with retinal injury and visual disability.

Entities:  

Mesh:

Year:  2009        PMID: 19667222      PMCID: PMC2784485          DOI: 10.1001/archneurol.2009.107

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  36 in total

1.  Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography.

Authors:  E Z Blumenthal; J M Williams; R N Weinreb; C A Girkin; C C Berry; L M Zangwill
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Tractography to depict three layers of visual field trajectories to the calcarine gyri.

Authors:  Takami Yamamoto; Kei Yamada; Tsunehiko Nishimura; Shigeru Kinoshita
Journal:  Am J Ophthalmol       Date:  2005-11       Impact factor: 5.258

3.  DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking.

Authors:  Hangyi Jiang; Peter C M van Zijl; Jinsuh Kim; Godfrey D Pearlson; Susumu Mori
Journal:  Comput Methods Programs Biomed       Date:  2006-01-18       Impact factor: 5.428

4.  Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging.

Authors:  S Mori; B J Crain; V P Chacko; P C van Zijl
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

Review 5.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 6.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis.

Authors:  D H Miller; R I Grossman; S C Reingold; H F McFarland
Journal:  Brain       Date:  1998-01       Impact factor: 13.501

7.  Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

Authors:  M A van Walderveen; F Barkhof; O R Hommes; C H Polman; H Tobi; S T Frequin; J Valk
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

8.  Optic radiation changes after optic neuritis detected by tractography-based group mapping.

Authors:  Olga Ciccarelli; Ahmed T Toosy; Simon J Hickman; Geoff J M Parker; Claudia A M Wheeler-Kingshott; David H Miller; Alan J Thompson
Journal:  Hum Brain Mapp       Date:  2005-07       Impact factor: 5.038

9.  Wallerian degeneration in the optic radiation after temporal lobectomy demonstrated in vivo with diffusion tensor imaging.

Authors:  U C Wieshmann; M R Symms; C A Clark; L Lemieux; F Franconi; G J Parker; G J Barker; S D Shorvon
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

10.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.

Authors:  S Anand Trip; Patricio G Schlottmann; Stephen J Jones; Daniel R Altmann; David F Garway-Heath; Alan J Thompson; Gordon T Plant; David H Miller
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

View more
  60 in total

1.  Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability.

Authors:  Hormuzdiyar H Dasenbrock; Seth A Smith; Arzu Ozturk; Sheena K Farrell; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

2.  Distinguishing and quantification of the human visual pathways using high-spatial-resolution diffusion tensor tractography.

Authors:  Arash Kamali; Khader M Hasan; Pavani Adapa; Azadeh Razmandi; Zafer Keser; John Lincoln; Larry A Kramer
Journal:  Magn Reson Imaging       Date:  2014-04-13       Impact factor: 2.546

3.  Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.

Authors:  Carmen Tur; Olivia Goodkin; Daniel R Altmann; Thomas M Jenkins; Katherine Miszkiel; Alessia Mirigliani; Camilla Fini; Claudia A M Gandini Wheeler-Kingshott; Alan J Thompson; Olga Ciccarelli; Ahmed T Toosy
Journal:  Brain       Date:  2016-02-17       Impact factor: 13.501

4.  Cerebral Vasoreactivity as an Indirect MRI Marker of White Matter Tracts Alterations in Multiple Sclerosis.

Authors:  Jeremy Deverdun; Arthur Coget; Xavier Ayrignac; Clarisse Carra-Dalliere; Alexandre Krainik; Aude Metzger; Pierre Labauge; Nicolas Menjot de Champfleur; Emmanuelle Le Bars
Journal:  Brain Topogr       Date:  2021-01-23       Impact factor: 3.020

5.  White matter consequences of retinal receptor and ganglion cell damage.

Authors:  Shumpei Ogawa; Hiromasa Takemura; Hiroshi Horiguchi; Masahiko Terao; Tomoki Haji; Franco Pestilli; Jason D Yeatman; Hiroshi Tsuneoka; Brian A Wandell; Yoichiro Masuda
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-25       Impact factor: 4.799

6.  Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study.

Authors:  Tim Sinnecker; Timm Oberwahrenbrock; Imke Metz; Hanna Zimmermann; Caspar F Pfueller; Lutz Harms; Klemens Ruprecht; Caren Ramien; Katrin Hahn; Wolfgang Brück; Thoralf Niendorf; Friedemann Paul; Alexander U Brandt; Jan Dörr; Jens Wuerfel
Journal:  Eur Radiol       Date:  2014-08-17       Impact factor: 5.315

7.  NONLINEAR TUBE-FITTING FOR THE ANALYSIS OF ANATOMICAL AND FUNCTIONAL STRUCTURES.

Authors:  Jeff Goldsmith; Brian Caffo; Ciprian Crainiceanu; Daniel Reich; Yong Du; Craig Hendrix
Journal:  Ann Appl Stat       Date:  2011-01-01       Impact factor: 2.083

8.  Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology.

Authors:  Peter A Calabresi; Laura J Balcer; Elliot M Frohman
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

9.  Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.

Authors:  Fiona Costello; William Hodge; Y Irene Pan; Jodie M Burton; Mark S Freedman; Peter K Stys; Jessie Trufyn; Randy Kardon
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

10.  Automated vs. conventional tractography in multiple sclerosis: variability and correlation with disability.

Authors:  Daniel S Reich; Arzu Ozturk; Peter A Calabresi; Susumu Mori
Journal:  Neuroimage       Date:  2009-11-26       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.